US OptionsDetailed Quotes

SNPS241220P480000

Watchlist

1.65
+0.81+96.43%

15min DelayClose Dec 13 16:00 ET

1.75High0.75Low

Synopsys Stock Discussion

10xStockPicks

3 minutes ago

Must BUY Esperion Therapeutics Selling FDA Approved Statin Alternative Drugs Will Soon Be Acquired Suspect The Analysts.

This unique biotech $Esperion Therapeutics (ESPR.US)$ Esperion has the only FDA approved statin alternative drugs NEXLIZET & NEXLETOL for Primary Prevention, Statins are a class of prescription drugs that help lower cholesterol levels. They are the most common treatment for high cholesterol, an estimated 21 Million Americans are Statin intolerant and or maxed out on Statin dru...

KyleyW

Dec 13 09:56

$Synopsys (SNPS.US)$ wtf, started strong and went down hill

Kevin Travers

Dec 5 15:50

Columns Thursday Indexes Pull back From Records While Bitcoin Sets New Ones | Wall Street Today

Bitcoin made headlines after breaking $100k, while equities pulled back across the market. By the close, indexes had fallen below their records set Wednesday.
Just past 4:36 pm ET the $S&P 500 Index (.SPX.US)$ fell 19 basis points, the $Dow Jones Industrial Average (.DJI.US)$ fell 0.55%, and the $Nasdaq Composite Index (.IXIC.US)$ fell 0.18%.
MACRO
Continuing jobless claims came in slightly below estimated, at 1.8...

Bitcoin breaks the $100,000 again: How high could it go?

Kevin Travers

Dec 5 10:18

Columns 100k Bitcoin! Market Pulls Back After Records | Live Stock

Good morning, traders. Happy Thursday, December 5th. My name is Kevin Travers, and Bitcoin hit 100k finally while the market is pulling back after Wednesday's top records for the S&P 500, Nasdaq, and Dow Jones. Here are the top news and animal spirits moving stocks:
$Synopsys (SNPS.US)$, a chip-making tool provider fell 11% Thursday after it reported its fourth-quarter earnings Wednesday afternoon. It posted adjusted EPS of $3.40, up 7% c...

Live Stock Financial Podcast. What are you watching on the market?

Movers and Shakers

Dec 5 07:37

Columns Today's Pre-Market Movers and Top Ratings | Five Below, Dollar General, Southwest Airlines and More

Morning Movers
Gapping up
$Dollar General (DG.US)$ stock rose 1.9% after the discount chain operator reported third-quarter revenue that surpassed expectations, while also trimming the upper end of its annual profit forecast on hurricane-related expenses.
$Southwest Airlines (LUV.US)$ stock rose 2.2% after the carrier revised its fourth-quarter revenue per available seat mile forecast upward, citing ...

Money Thrill

Dec 4 15:44

Synopsys Posts Financial Results for Fourth Quarter and Fiscal Year 2024/ 4 december

$Synopsys (SNPS.US)$ Results Summary
Record quarterly revenue of $1.636 billion, up approximately 11% year over year (YoY), exceeding the mid-point of guidance.
Quarterly GAAP earnings per diluted share (EPS) of $1.79; non-GAAP EPS of $3.40, up approximately 13% YoY, exceeding guidance.
Achieved record full-year 2024 revenue of $6.127 billion, up approximately 15% YoY, while improving non-GAAP operating margin a...